Clinical Trial: Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes

U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07854990) titled 'Clinical Predictors and Therapeutic Gaps in CKM Syndrome Among Adults With Type 2 Diabetes' on Sept. 27.

Brief Summary: Type 2 diabetes (T2D) is a principal driver of cardiovascular-renal-metabolic (CKM) syndrome, where metabolic, renal, and cardiac dysfunction accelerate disease progression. This cross-sectional study aims to classify adult patients with T2D attending outpatient clinics at Assiut University Hospitals across CKM stages (0-4) according to the 2023 American Heart Association (AHA) staging system. Additionally, the study identifies independent clinical and laboratory predictors of advanced CKM stages (Stages 3-4) and qu...